Epigral Limited has informed the Exchange about Copy of Newspaper Publication
EPIGRAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Epigral Limited has shared copies of newspaper advertisements published on May 6, 2025 in Financial Express (English and Gujarati editions) containing its audited consolidated and standalone financial results for Q4 FY25 and the full year ended March 31, 2025, as required under SEBI Listing Regulations. Consolidated revenue from operations for FY25 stood at ₹2,550.13 Cr, up about 32% from ₹1,929.19 Cr in FY24. Profit before tax for FY25 rose to ₹541.09 Cr (vs ₹290.75 Cr), and net profit after tax jumped to ₹357.69 Cr (vs ₹195.87 Cr), an increase of roughly 83% year-on-year. Basic EPS for FY25 was ₹84.68 versus ₹47.14 in FY24. For the standalone Q4, revenue was ₹627.63 Cr with a PAT of ₹86.62 Cr. The results had been reviewed by the Audit Committee and approved by the Board on May 5, 2025.
The disclosure itself is a regulatory newspaper publication and is unlikely to move the stock, but the underlying results show strong double-digit revenue growth and an ~83% jump in full-year net profit, which is a positive sign for shareholders.